YOUR BUSINESS AUTHORITY
Springfield, MO
The U.S. government agreed to pay $1.2 billion to AstraZeneca PLC to secure its supply of a potential COVID-19 vaccine.
The deal calls for the government to fund a 30,000-person vaccine trial starting this summer. The investment also would support the ramp-up of manufacturing capacity to make at least 300 million doses.
The vaccine was developed by the University of Oxford’s Jenner Institute.
Read more from MarketWatch.
Organizers hope to bolster client traffic to center city businesses.